Disease: Neutropenia monocytopenia deafness
- A phase 3 randomized crossover trial of plerixafor versus G-CSF for treatment of WHIM syndrome
- A phase III randomized crossover trial of plerixafor versus G-CSF for treatment of WHIM syndrome
- Acquired Senescent T-Cell Phenotype Correlates with Clinical Severity in GATA Binding Protein 2-Deficient Patients
- Diffuse parenchymal lung disease as first clinical manifestation of GATA-2 deficiency in childhood
- Neutropenia, recurrent bacterial infections, and congenital deafness in patients with monocytopenia. Absence of peripheral blood colony-stimulating activity
- Spectrum of myeloid neoplasms and immune deficiency associated with germline GATA2 mutations